Molecules that protect brain cells from Parkinson’s identifiedDecember 29th, 2009 - 2:43 pm ICT by ANI
Washington, Dec 29 (ANI): Whitehead Institute researchers claim to have identified small molecules that appear to be capable of protecting brain cells from alpha-synuclein toxicity, a hallmark of Parkinson’s disease.
During the study, the team came across four related small molecules that prevented the development of several cellular traits associated with Parkinson’s disease, including the accumulation of alpha-synuclein deposits in the cell, improper protein trafficking from one organelle to another, and damage inflicted on the cells’ engines, the mitochondria.
“In this research, we used yeast as a Parkinson’s disease model system to identify the compounds that really work in two higher order model systems of Parkinson’s,” said Julie Su, a first co-author on the paper describing the research and a former postdoctoral researcher in Whitehead Member Susan Lindquist’s lab.
The yeast was modified to produce too much of the alpha-synuclein protein in its cells. The resulting cells manifest adverse effects similar to those experienced in brain cells from Parkinson’s patients.
Using this yeast strain, the Lindquist team screened 115,000 small compounds to see which ones alleviate the Parkinson’s-like traits. During a screen, a compound is added to a small amount of yeast
Four compounds were found to restore the alpha-synuclein yeast cells’ growth to 50pc of normal yeast cells. Yeast cells that were not treated with the compounds died.
The researchers also identified two commercially available compounds with similar chemical structures and used those in further tests.
In the study conducted using round worm Caenorhabditis elegans and rat neurons, the first four compounds were able to rescue the round worms, while in the rat neurons, three of the four original compounds and one of the commercial compounds improved the nerve cells’ growth.
“Those two things are obviously related,” said Pavan Auluck, first co-author and a visiting scientist in the Lindquist lab.
“We’re trying to figure out what the connections are between them. And there are a number of ways they can be related,” Auluck added.
“There are very deeply rooted processes that connect protein trafficking and mitochondrial viability,” said Lindquist, who is also a Howard Hughes Medical Institute investigator and a professor of biology at MIT. “That emphasizes that the underlying problem caused by alpha-synuclein is a general cellular defect that is part of the machinery of all eukaryotic cells. The specific problems in Parkinson’s are due to the neurons being particularly sensitive to that process going awry.”
The study appears in Disease Models and Mechanisms (DMM). (ANI)
- Yeast offers clues to Parkinson's disease - Sep 09, 2010
- Toxin that plays key role in triggering Parkinson's disease identified - Feb 11, 2011
- Study provides new insight into Parkinson's disease - Apr 05, 2011
- Turmeric compound shows promise in Parkinson's - Mar 21, 2012
- Now, a new approach to calculate gene, protein connections in a Parkinson''s disease - Feb 23, 2009
- Protein pathway find may help solve Parkinson's disease - Mar 01, 2011
- Mouse model confirms mutated protein plays role in dementia - Nov 03, 2010
- How Parkinson's disease spreads in the brain - Jul 28, 2009
- New tests to detect Parkinson's disease early on - Sep 27, 2010
- Unexpected biological pathway in glaucoma discovered - Jan 04, 2011
- New compounds may help develop drugs for degenerative nerve diseases - Jan 20, 2010
- Novel molecular pathway underlying Parkinson's disease identified - Sep 14, 2010
- Sense of smell test key to tackling Parkinson's disease - Jun 12, 2010
- Scientists identify 'molecule trio' that kills neurons in Parkinson's - Apr 30, 2009
- Scientists produce compound that may treat Parkinson's disease - Feb 12, 2011
Tags: alpha synuclein, brain cells, chemical structures, disease model, elegans, institute researchers, mitochondria, model system, model systems, nerve cells, organelle, parkinson s disease, pavan, postdoctoral researcher, protein trafficking, rat neurons, susan lindquist, whitehead institute, yeast cells, yeast strain